Jay Markowitz
Chief Executive Officer bei REVOLUTION HEALTHCARE ACQUISITION CORP.
Profil
Jay S.
Markowitz, M.D.
has spent 19 years analyzing, investing, and working in the biopharmaceutical industry.
He is currently a Senior Partner at ARCH, joining the firm in 2021.
In 2020 he was a Vice President and Sector Portfolio Manager at T.
Rowe Price; from 2017-2020 he was a Senior Vice President at Regeneron Pharmaceuticals; from 2010-2017 he was the U.S.
pharmaceutical and biotechnology analyst at Capital World Investors; and from 2002-2010 he was a biotechnology analyst with investment responsibility at T.
Rowe Price.
Before transitioning to an investment career, he was an assistant professor and transplant surgeon at the Johns Hopkins University School of Medicine (1999-2002) and the University of Medicine and Dentistry of New Jersey (1997-1999).
Dr. Markowitz received his B.A.
from Columbia University and his M.D.
from Duke University.
He completed a fellowship in transplant surgery at the UCLA Medical Center, a surgical residency at Massachusetts General Hospital, and a Research Fellowship in Cellular and Molecular Immunology at the Harvard School of Public Health.
Aktive Positionen von Jay Markowitz
| Unternehmen | Position | Beginn |
|---|---|---|
| REVOLUTION HEALTHCARE ACQUISITION CORP. | Chief Executive Officer | - |
ARCH Venture Partners LLC
 ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners LLC is a Venture Capital firm founded in 1986. The firm is headquartered in Chicago with additional office in Dublin. | Private Equity Investor | 01.01.2021 |
Paradigm Health, Inc.
 Paradigm Health, Inc. Packaged SoftwareTechnology Services Paradigm Health, Inc. develops a platform for clinical research. The company is based in New York, NY and has subsidiaries in the United States. The company was founded by Milind Kamkolkar. Kent Thoelke has been the CEO of the company since 2023. | Director/Board Member | - |
Ehemalige bekannte Positionen von Jay Markowitz
| Unternehmen | Position | Ende |
|---|---|---|
| REGENERON PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.01.2020 |
| The Johns Hopkins University School of Medicine | Corporate Officer/Principal | 01.01.2002 |
| University of Medicine & Dentistry of New Jersey | Corporate Officer/Principal | 01.01.1999 |
Capital Research & Management Co. (World Investors)
 Capital Research & Management Co. (World Investors) Investment ManagersFinance Capital Research & Management Co., doing business as Capital World Investors (CWI), is an investment advisor headquartered in Los Angeles, California. The firm is a division of Capital Research & Management Co., which is ultimately owned by the Capital Group of Cos. In 2013, The Capital Group restructured its equity investment group and divided the group based on specific investment objectives rather than around particular products or clients. The investment group is now divided into three independent equity divisions, Capital World Investors, Capital Research Global Investors and Capital International Investors. Each division has the flexibility to manage any of the investment objectives or any of the investment vehicles the Capital Group offers. CWI is the retail entity of the Capital Group. | Analyst-Equity | - |
T. Rowe Price Associates, Inc. (Investment Management)
 T. Rowe Price Associates, Inc. (Investment Management) Investment ManagersFinance T. Rowe Price Associates, Inc. (Price Associates) is a registered investment advisor and mutual fund manager headquartered in Baltimore, Maryland. The firm was founded by Thomas Rowe Price, Jr. in 1937. They are a subsidiary of the T. Rowe Price Group, Inc. (NASDAQ: TROW), which was formed in 2000 as the publicly traded parent holding company of Price Associates and their affiliated entities. Price Associates offers a variety of mutual funds, sub-advisory services and separate account management for individual and institutional investors, retirement plans and financial intermediaries. | Analyst-Equity | 10.01.2010 |
Ausbildung von Jay Markowitz
| The Trustees of Columbia University in The City of New York | Undergraduate Degree |
| Duke University | Doctorate Degree |
| Columbia University School of the Arts | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| REGENERON PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
T. Rowe Price Associates, Inc. (Investment Management)
T. Rowe Price Associates, Inc. (Investment Management) Investment ManagersFinance T. Rowe Price Associates, Inc. (Price Associates) is a registered investment advisor and mutual fund manager headquartered in Baltimore, Maryland. The firm was founded by Thomas Rowe Price, Jr. in 1937. They are a subsidiary of the T. Rowe Price Group, Inc. (NASDAQ: TROW), which was formed in 2000 as the publicly traded parent holding company of Price Associates and their affiliated entities. Price Associates offers a variety of mutual funds, sub-advisory services and separate account management for individual and institutional investors, retirement plans and financial intermediaries. | Finance |
ARCH Venture Partners LLC
ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners LLC is a Venture Capital firm founded in 1986. The firm is headquartered in Chicago with additional office in Dublin. | Finance |
Capital Research & Management Co. (World Investors)
Capital Research & Management Co. (World Investors) Investment ManagersFinance Capital Research & Management Co., doing business as Capital World Investors (CWI), is an investment advisor headquartered in Los Angeles, California. The firm is a division of Capital Research & Management Co., which is ultimately owned by the Capital Group of Cos. In 2013, The Capital Group restructured its equity investment group and divided the group based on specific investment objectives rather than around particular products or clients. The investment group is now divided into three independent equity divisions, Capital World Investors, Capital Research Global Investors and Capital International Investors. Each division has the flexibility to manage any of the investment objectives or any of the investment vehicles the Capital Group offers. CWI is the retail entity of the Capital Group. | Finance |
Revolution Healthcare Acquisition Corp.
 Revolution Healthcare Acquisition Corp. Financial ConglomeratesFinance Revolution Healthcare Acquisition Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination. The company was founded on January 11, 2021 and is headquartered in Cambridge, MA. | Finance |
Paradigm Health, Inc.
Paradigm Health, Inc. Packaged SoftwareTechnology Services Paradigm Health, Inc. develops a platform for clinical research. The company is based in New York, NY and has subsidiaries in the United States. The company was founded by Milind Kamkolkar. Kent Thoelke has been the CEO of the company since 2023. | Technology Services |
